Intellectual Property (IP)

Intellectual Property (IP) encompasses legal rights protecting inventions, designs, processes, and proprietary knowledge, enabling innovators to control commercial use and secure competitive advantage. In the biopharmaceutical context, IP includes patents covering drug compounds, biologic sequences, manufacturing processes, formulations, delivery systems, and therapeutic indications, alongside trade secrets and regulatory exclusivities.

The pharmaceutical industry relies on IP strategy as a core component of product development and commercial planning. Patents are filed early to protect novel targets, molecules, or platforms, while later filings may cover improved formulations, dosing regimens, combinations, or manufacturing innovations. Freedom-to-operate analyses assess whether development infringes existing patents, guiding licensing or design changes. Regulatory exclusivities complement patents through defined market protection periods for orphan drugs, paediatric studies, or data protection frameworks. As competition increases and innovation accelerates, IP management remains essential for sustaining innovation incentives while shaping market access and long-term commercial success.